| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 06/13/2006 | US7060836 Lactams as tachykinin antagonists |
| 06/13/2006 | US7060827 Intermediates useful for making 2,4-pyrimidinediamine compounds |
| 06/13/2006 | US7060824 Pyrrolotriazolopyrimidinone derivatives |
| 06/13/2006 | US7060731 Such as meglumine, 3-methylamino-1,2 propandiol or 2-(methylamino)-ethanol as complement inhibitors, to combact activation of the kinin/kallikrein system or as an anticoagulant |
| 06/13/2006 | US7060730 Rapidly absorbed liquid compositions |
| 06/13/2006 | US7060716 Compound containing two triple bonds |
| 06/13/2006 | US7060712 Crystalline form of aryl aniline β2 adrenergic receptor agonist |
| 06/13/2006 | US7060701 piperidines or piperazines 1-linked to a 1-(1-carbonylpiperidin-4-yl)piperidinyl- group through an optionally substituted methyl group; treating Human Immuno-deficiency Virus, solid organ transplant rejection, arthritis, rheumatoid arthritis, and multiple sclerosis |
| 06/13/2006 | US7060700 Amide derivatives useful as inhibitors of the production of cytokines |
| 06/13/2006 | US7060699 Aryl and heteroaryl diazabicycloalkanes, their preparation and use |
| 06/13/2006 | US7060691 Pharmaceutical colloidal preparation useful in the treatment of respiratory diseases |
| 06/13/2006 | US7060685 Benzylaminosulfonic Acid or portion or analogue linked to a carbohydrate or glycomimetic for modulating processes mediated by selectin binding such as autoimmune and inflammatory diseases, shock and reperfusion injuries |
| 06/13/2006 | US7060302 Metal-containing compositions, preparations and uses |
| 06/08/2006 | WO2006059945A1 Novel compounds |
| 06/08/2006 | WO2006059801A1 7-membered ring compound, process for producing the same, and medicinal use thereof |
| 06/08/2006 | WO2006059778A1 Substituted pyridone derivative |
| 06/08/2006 | WO2006058867A2 Substituted pteridines for the treatment of inflammatory diseases |
| 06/08/2006 | WO2006058724A1 New pyridothienopyrimidine derivatives |
| 06/08/2006 | WO2006058723A1 New pyridothienopyrimidine derivatives |
| 06/08/2006 | WO2006035280A8 3,4-dihydroisoquinoline compounds as muscrinic receptor antagonists for the treatment of respiratory, urinary and gastrointestinal diseases |
| 06/08/2006 | WO2006010503A3 Rxr antagonists in the treatment of inflammatory diseases |
| 06/08/2006 | US20060122411 Chloride channel opener |
| 06/08/2006 | US20060122392 Tri-heterocyclic compounds and a pharmaceutical comprising them as an active ingredient |
| 06/08/2006 | US20060122390 Boronic ester and acid compounds, synthesis and uses |
| 06/08/2006 | US20060122249 Condensed heterocyclic pyrazole derivatives as kinase inhibitors |
| 06/08/2006 | US20060122243 Antiallergic |
| 06/08/2006 | US20060122221 N-[4-methyl-3-(3-piperidin-4-yl-1,2-benzisoxazol-6-yl)phenyl]-2-pyrrolidin-1-ylisonicotinamide; rheumatoid arthritis |
| 06/08/2006 | US20060122215 Preparation and use of 1,5,6,7-tetrahydropyrrolo[3,2-C]pyridine derivatives for the treatment of obesity |
| 06/08/2006 | US20060122195 Sulphonamide compounds that modulate chemokine receptor activity (ccr4) |
| 06/08/2006 | US20060122192 Chemical compounds |
| 06/08/2006 | US20060122176 such as 5-(1,3-benzodioxol-5-ylmethylene)-1,3-thiazolidine-2,4-dione, used for the treatment and/or prophylaxis of autoimmune, cardiovascular or neurodegenerative disorders, inflammatory or kidney diseases, bacterial or viral infections, platelet aggregation, cancer, transplant rejection or lung injuries |
| 06/08/2006 | US20060121529 CpG receptor (CpG-R) and methods relating thereto |
| 06/08/2006 | US20060121521 Cold-adapted equine influenza viruses |
| 06/08/2006 | US20060121514 Prostacyclin-stimulating Factor-2 |
| 06/08/2006 | US20060121180 Using electrochemical solution containing metal compound and bioactive materials; contacting substrate |
| 06/08/2006 | US20060121128 Increasing cytosolic calcium levels in airway epithelial cell by contacting purinergic (P2X) receptors on cell with zinc chloride; cystic fibrosis, asthma, allergies, polycystic kidney disease and salt-sensitive hypertension syndromes, diabetes; drug screening; nasal spray |
| 06/08/2006 | US20060121117 Anti-angiogenic compositions and methods of use |
| 06/08/2006 | US20060121088 delivering to an external portion of the body passageway a therapeutic agent such as an antiangiogenic factor from a thread; treating stenosis or restenosis for example |
| 06/08/2006 | US20060121029 Method and composition for regulating the activity of regulatory t cells |
| 06/08/2006 | US20060121015 Probiotic bifidobacterium strains |
| 06/08/2006 | US20060120966 Salmeterol superfine formulation |
| 06/08/2006 | DE102004057595A1 Substituierte Pteridine zur Behandlung von entzündlichen Erkrankungen Substituted pteridines for the treatment of inflammatory diseases |
| 06/08/2006 | CA2589638A1 7-membered ring compound and method of production and pharmaceutical application thereof |
| 06/08/2006 | CA2588892A1 Anti-il-1r1 single domain antibodies and therapeutic uses |
| 06/08/2006 | CA2588867A1 Substituted pyridone derivative |
| 06/08/2006 | CA2588808A1 New pyridothienopyrimidine derivatives |
| 06/08/2006 | CA2588741A1 New pyridothienopyrimidine derivatives |
| 06/08/2006 | CA2587261A1 Substituted pteridines for the treatment of inflammatory diseases |
| 06/07/2006 | EP1666481A2 Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine and the use thereof for the preparation of pyrrolo[2,3]pyrimidine derivatives as protein kinases inhibitors |
| 06/07/2006 | EP1666480A1 Aryl or Heteroaryl Fused Imidazole Compounds as intermediates for Anti-Inflammatory And Analgesic Agents. |
| 06/07/2006 | EP1666473A1 Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient |
| 06/07/2006 | EP1666092A2 Drug combination comprising a fatty acid and a uridine compound. |
| 06/07/2006 | EP1666063A2 Method for treatment of fibrosis using an antagonist of the integrin alpha-4 subunit |
| 06/07/2006 | EP1666062A2 Therapeutic applications for the anti-T-BAM (CD40-L) monoclonal antibody 5c8 |
| 06/07/2006 | EP1666058A2 Method of and compositions for immunization with the pseudomonas V antigen |
| 06/07/2006 | EP1666047A1 Pharmaceutical compositions comprising nitric oxide-releasing pyrrolidones |
| 06/07/2006 | EP1666028A1 Dry powder compositions having improved dispersivity |
| 06/07/2006 | EP1664058A1 Substituted thienoimidazoles, method for production and use thereof as medicament or diagnostic and medicaments comprising the same |
| 06/07/2006 | EP1664057A1 Polyether brevetoxin derivatives as a treatment for cystic fibrosis, mucociliary dysfunction, and pulmonary diseases |
| 06/07/2006 | EP1663983A1 N-substituted, 6,8-dialkoxy-1,2,3,4-tetrahydro-1h-isoquinoline as potassium channels modulators |
| 06/07/2006 | EP1663982A1 Aminoquinoline derivatives and their use as adenosine a3 ligands |
| 06/07/2006 | EP1663958A2 Haloalkyl containing compounds as cysteine protease inhibitors |
| 06/07/2006 | EP1663270A1 Method for the production of ivy leaf extracts, and extract produced according to said method |
| 06/07/2006 | EP1663269A1 Method for the production of a storage-resistant ivy leaf extract, and extract produced according to said method |
| 06/07/2006 | EP1663256A1 Carbohydrate composition and its use for the preparation of a medicament for treating or preventing pulmonary inflammation or acute respiration distress syndrome |
| 06/07/2006 | EP1663235A1 Capped pyrazinoylguanidine sodium channel blockers |
| 06/07/2006 | EP1663197A1 The use of fumaric acid derivatives for treating cardiac insufficiency, and asthma |
| 06/07/2006 | EP1663151A2 Mucoactive agents for treating a pulmonary disease |
| 06/07/2006 | EP1492789B1 Tropane derivatives as ccr5 modulators |
| 06/07/2006 | EP1421075B1 Piperidine derivatives useful as ccr5 antagonists for the treatment of hiv |
| 06/07/2006 | EP1406878B1 4-(benzylidene-amino)-3-(methylsulfanyl)-4h-(1, 2, 4) triazin-5-one derivatives having a pde-iv inhibiting and tnf-antagonistic effect for the treatment of cardiac diseases and allergies |
| 06/07/2006 | EP1378510B1 Triazaspiro (5.5) undecane derivatives and drugs containing the same as the active ingredient |
| 06/07/2006 | EP1368355B1 Substituted pyrazolopyrimidines and thiazolopyrimidines |
| 06/07/2006 | EP1364023B1 Gene highly expressed in cartilage tissues |
| 06/07/2006 | EP1311478B1 Novel (thio)urea compounds and the pharmaceutical compositions containing the same |
| 06/07/2006 | EP1309559B1 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 06/07/2006 | EP1254234B1 Haemophilus influenza outer membrane protein and use thereof in vaccination |
| 06/07/2006 | EP1107794B1 Therapeutic compositions for the treatment of mucus hypersecretion |
| 06/07/2006 | EP1071463B1 Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors |
| 06/07/2006 | EP1002081B1 Delayed progression to aids by a missense allele of the ccr2 gene |
| 06/07/2006 | EP0813538B1 Compositions and methods for the treatment and diagnosis of immune disorders |
| 06/07/2006 | CN1784405A Microcrystal |
| 06/07/2006 | CN1784403A Azaindole compounds as kinase inhibitors |
| 06/07/2006 | CN1784402A Imidazo and thiazolopyridines as JAK3 kinase inhibitors |
| 06/07/2006 | CN1784400A Quinuclidine derivatives binding to mucarinic M3 receptors |
| 06/07/2006 | CN1781920A Polycyclic guanine phosphodiesterase v inhibitor |
| 06/07/2006 | CN1781890A 糖皮质激素受体调制剂 Glucocorticoid receptor modulators |
| 06/07/2006 | CN1781547A Plaster for clearing lung, relieving asthma and stopping cough |
| 06/07/2006 | CN1781537A Shengmai injection and its preparing method |
| 06/07/2006 | CN1781523A Schisandra chinensis soft capsule |
| 06/07/2006 | CN1781517A Medicine containing zinc element for treating rhinitis and other disease |
| 06/07/2006 | CN1781508A Natural cough stopping oral liquor |
| 06/07/2006 | CN1258533C Antihistaminic spiro compounds |
| 06/07/2006 | CN1258526C Substituted beta-diketones and their use |
| 06/07/2006 | CN1258362C Use of substituted acryloyl stallimycin derivatives in treatment of tumors associated with high levels of glutathione |
| 06/06/2006 | US7056944 Pyrazole compositions useful as inhibitors of erk |
| 06/06/2006 | US7056937 Sulfonylquinoxalone derivatives as bradykinin antagonists |
| 06/06/2006 | US7056936 Synergistic combination |
| 06/06/2006 | US7056933 For therapy of arthritis, fever, common cold, dysmenorrhea, menstrual cramps, inflammatory bowel disease, Crohn's disease, emphysema, acute respiratory distress syndrome, asthma, bronchitis, chronic obstructive pulmonary disease, etc. |
| 06/06/2006 | US7056915 Compounds useful as reversible inhibitors of cysteine proteases |